AU699199B2 - The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (HP) associated syndromes and infectious diseases - Google Patents

The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (HP) associated syndromes and infectious diseases

Info

Publication number
AU699199B2
AU699199B2 AU20713/95A AU2071395A AU699199B2 AU 699199 B2 AU699199 B2 AU 699199B2 AU 20713/95 A AU20713/95 A AU 20713/95A AU 2071395 A AU2071395 A AU 2071395A AU 699199 B2 AU699199 B2 AU 699199B2
Authority
AU
Australia
Prior art keywords
therapy
dimeticone
helicobacter pylori
prevention
infectious diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU20713/95A
Other languages
English (en)
Other versions
AU2071395A (en
Inventor
Alfred Schmidt
Hans-Jurgen Upmeyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/EP1995/000972 external-priority patent/WO1995025525A1/fr
Publication of AU2071395A publication Critical patent/AU2071395A/en
Application granted granted Critical
Publication of AU699199B2 publication Critical patent/AU699199B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU20713/95A 1994-03-18 1995-03-15 The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (HP) associated syndromes and infectious diseases Ceased AU699199B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4409357A DE4409357C2 (de) 1994-03-18 1994-03-18 Verwendung von Dimeticon zur Eradikation von Heliobacter pylori
DEP4409357 1994-03-18
PCT/EP1995/000972 WO1995025525A1 (fr) 1994-03-18 1995-03-15 Utilisation de dimeticone dans la therapie antibacterienne locale et/ou la prevention et la therapie des syndromes et maladies infectieuses associes a helicobacter pylori (hp)

Publications (2)

Publication Number Publication Date
AU2071395A AU2071395A (en) 1995-10-09
AU699199B2 true AU699199B2 (en) 1998-11-26

Family

ID=6513210

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20713/95A Ceased AU699199B2 (en) 1994-03-18 1995-03-15 The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (HP) associated syndromes and infectious diseases

Country Status (14)

Country Link
EP (1) EP0804242A1 (fr)
JP (1) JPH09510466A (fr)
CN (1) CN1244129A (fr)
AU (1) AU699199B2 (fr)
CA (1) CA2185882A1 (fr)
CZ (1) CZ300796A3 (fr)
DE (1) DE4409357C2 (fr)
FI (1) FI963682A (fr)
HU (1) HU215595B (fr)
NO (1) NO963893L (fr)
NZ (1) NZ282805A (fr)
PL (1) PL316307A1 (fr)
SK (1) SK132496A3 (fr)
WO (1) WO1995025545A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100245A (en) * 1999-09-07 2000-08-08 Mcneil-Ppc, Inc. Use of simethicone to treat ulcerative colitis
MXPA05012791A (es) * 2003-05-25 2006-02-22 Wang Yuwan Formulacion sostenida que contiene dimeticona.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120533A (en) * 1989-01-19 1992-06-09 Steigerwald Arzneimittelwerk Gmbh Treatment of ulcers of the gastrointestinal tract using dimethylpolysiloxane

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3848M (fr) * 1964-05-04 1966-01-17 Robert Schapiro Associations thérapeutiques pour traitement de nombreux troubles digestifs organiques ou fonctionnels.
GB1357737A (en) * 1970-10-09 1974-06-26 Arpic Sa Sustained release pharmaceutical compositions
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
US4837029A (en) * 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Low foaming, aqueously homogenizable rifampin composition
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
IE903302A1 (en) * 1989-09-15 1991-04-10 Pehrom Pharmaceutical Corp Topical preparation for treatment of aphthous ulcers and¹other lesions
IN171919B (fr) * 1989-11-01 1993-02-06 Mcneil Ppc Inc
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn
WO1994003209A1 (fr) * 1992-07-29 1994-02-17 Merck & Co., Inc. Combinaisons dexibuprofene/antacide/simethicone

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120533A (en) * 1989-01-19 1992-06-09 Steigerwald Arzneimittelwerk Gmbh Treatment of ulcers of the gastrointestinal tract using dimethylpolysiloxane

Also Published As

Publication number Publication date
HU215595B (hu) 1999-01-28
NO963893L (no) 1996-11-04
CA2185882A1 (fr) 1995-09-28
NO963893D0 (no) 1996-09-17
WO1995025545A1 (fr) 1995-09-28
DE4409357C2 (de) 1996-10-17
NZ282805A (en) 1998-02-26
PL316307A1 (en) 1997-01-06
FI963682A (fi) 1996-11-13
CZ300796A3 (en) 1997-09-17
CN1244129A (zh) 2000-02-09
EP0804242A1 (fr) 1997-11-05
AU2071395A (en) 1995-10-09
HU9602839D0 (en) 1996-12-30
HUT75711A (en) 1997-05-28
SK132496A3 (en) 1997-06-04
JPH09510466A (ja) 1997-10-21
FI963682A0 (fi) 1996-09-17
DE4409357A1 (de) 1995-09-21

Similar Documents

Publication Publication Date Title
US5538729A (en) Oral treatment of helicobacter infection
Axon Helicobacter pylori infection
AU590578B2 (en) Treatment of non-ulcer dyspepsia with bismuth salts
RU2227033C2 (ru) Тауролидин и/или таурултам при лечении инфекционной язвенной болезни или инфекционного гастрита
WO1995025525A1 (fr) Utilisation de dimeticone dans la therapie antibacterienne locale et/ou la prevention et la therapie des syndromes et maladies infectieuses associes a helicobacter pylori (hp)
EP0484148A1 (fr) Procédé de préparation d'un médicament pour à la fois, le traitement et la prévention d'ulcères peptiques gastriques et de la gastrite, et des médicaments ainsi formulés
Axon Eradication of Helicobacter pylori
AU699199B2 (en) The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (HP) associated syndromes and infectious diseases
Palmer Gastrointestinal diseases of foals
US6028062A (en) Use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (Hp) associated syndromes and infectious diseases
Gupta et al. Eradication of H. pylori in a developing country: comparison of lansoprazole versus omeprazole with norfloxacin, in a dual-therapy study.
US4959384A (en) Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders
Catalano et al. Helicobacter pylori-Positive Functional Dyspepsia in Elderly Patients Comparison of Two Treatments
US5229380A (en) Method for treating helicobacter pylori gastritis
Spadaccini et al. Omeprazole versus ranitidine: short‐term triple‐therapy in patients with Helicobacter pylori‐positive duodenal ulcers
Lam et al. Sucralfate in Helicobacter pylori eradication strategies
Fukuda Suppression of Helicobacter pylori colonization with omeprazole
RU2187318C2 (ru) Способ лечения хронического гастрита и язвенной болезни двенадцатиперстной кишки
CN1273193C (zh) 抗幽门螺杆菌卵黄抗体生物制剂的制备方法
AU675938C (en) Oral treatment of helicobacter infection
Ndidi Gastric Ulcers; Causes, Symptoms, Treatment, and Prevention
KR970020114A (ko) 찹쌀추출물을 함유하는 항궤양제 및 궤양 예방을 위한 음료
Kato et al. Traditional and non-traditional antimicrobial agents for H. pylori infection
ISLAM et al. HELICOBACTER PYLORI COLONISATION OF THE ANTRUM AND INCIDENCE OF PEPTIC ULCER
RU95101369A (ru) Противоязвенное средство

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired